Cite
APA Citation
Weihrauch, M. R., Richly, H., von Bergwelt-Baildon, M. S., Becker, H. J., Schmidt, M., Hacker, U. T., Shimabukuro-Vornhagen, A., Holtick, U., Nokay, B., Schroff, M., Wittig, B., & Scheulen, M. E. (n.d.). phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours. European journal of cancer, 51(2), 146–156. http://access.bl.uk/ark:/81055/vdc_100025859416.0x000026